首页> 外国专利> APC T Method for Ex-vivo Expansion of Regulatory T cells Using Autologous Antigen-Presenting Cell and Uses Thereof

APC T Method for Ex-vivo Expansion of Regulatory T cells Using Autologous Antigen-Presenting Cell and Uses Thereof

机译:使用自体抗原呈递细胞在体外扩增调节性T细胞的APC T方法及其用途

摘要

The present invention relates to a method of in vitro propagation of regulatory T cells using autologous APCs and their use,+Treg and CD4-Preparing PBMCs respectively; And (b)+Tregs were incubated with the CD4-PBMC, anti-CD3 antibody, anti-CD28 antibody, IL2 (interleukin2) and TGF-b (beta)+Proliferating CD4 RTI ID = 0.0 +A method for inhibiting organ transplant rejection, and a pharmaceutical composition for preventing or treating an autoimmune disease or an inflammatory disease. Since the method of the present invention mass-regulates regulatory T cells and the amplified regulatory T cells exhibit an excellent immunosuppressive effect, it is possible to overcome various immune rejection reactions occurring in the recipient during transplantation of the same or different organs Can be effectively used.;
机译:本发明涉及利用自体APCs体外培养调节性T细胞的方法及其用途,分别制备 + Treg和CD4 - PBMC。然后将(b) + Treg与CD4 - PBMC,抗CD3抗体,抗CD28抗体,IL2(interleukin2)和TGF-b(beta) Sup> + Sup> CD4的增殖抑制器官移植排斥的方法和预防或治疗自身免疫性疾病或炎性疾病的药物组合物。由于本发明的方法大量调节调节性T细胞,并且扩增的调节性T细胞显示出优异的免疫抑制作用,因此有可能克服在相同或不同器官的移植过程中在受体中发生的各种免疫排斥反应。 。;

著录项

  • 公开/公告号KR101757269B1

    专利类型

  • 公开/公告日2017-07-12

    原文格式PDF

  • 申请/专利权人 서울대학교산학협력단;

    申请/专利号KR20150062802

  • 发明设计人 박정규;임동균;김정식;

    申请日2015-05-04

  • 分类号C12N5/00;A61K35/17;C12N5/0783;

  • 国家 KR

  • 入库时间 2022-08-21 13:25:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号